ASCO 2015: Affibody imaging agent may supplant biopsy for some breast cancer patients
LONDON A new non-invasive imaging agent has shown there can be unexpected changes in human epidermal growth factor receptor type 2 (HER2) status from primary breast cancer to metastatic disease, and that as a result some women are inappropriately being treated with HER2 positive-targeted drugs.
Doctoring Twitter; HRS 2015 and social media
This year's edition of the Heart Rhythm Society annual scientific sessions is in the can, and there were a number of interesting related developments inside and outside the confines of the Boston Convention and Exhibition Center. While the content was fascinating, there was also a lot about social media that was quite interesting as well.
EuroPCR 2015: Safer, efficient TAVI challenges surgery as gold standard
PARIS Citing clinical results they qualified as "fabulous," and "impressive," two key opinion leaders affiliated with Edwards Lifesciences (Irvine, California) are calling for an end to the dominance of open-chest surgery as the gold standard for treating patients with stenosis of the aortic valve.